226
Views
21
CrossRef citations to date
0
Altmetric
Special Section - Original Research

When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers

, MD, MS, , , MPH, , MD, MS, , MD, MBA, , MD, MPH & , MD, MS show all
Pages 148-153 | Received 20 Jul 2015, Accepted 01 Dec 2015, Published online: 20 Mar 2016

References

  • Silverberg MJ, Ray GT, Saunders K, et al. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012;28:39–46.
  • Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan BJ, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: The TROUP study. Pain. 2008;138:440–449.
  • Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage. 2004;28:176–188.
  • Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710–1714.
  • Cohen SM, Van Handel MM, Branson BM, Blair JM, Hall HI, Hu X, Koenig LJ, Jacek Skarbinski J, Tracey A, Mermin J, et al., Div of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618–1623.
  • Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130.
  • Washington State Agency Medical Directors' Group. Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain. http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf. Published 2010. Accessed February 15, 2016.
  • Utah Department of Health. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City, UT. Available at: http://www.dopl.utah.gov/licensing/forms/OpioidGuidlines.pdf. Published 2009. Accessed September 30, 2011.
  • Federation of State Medical Boards of the United States. Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain. Federation of State Medical Boards of the United States. http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/pain_policy_july2013.pdf. Published 2013. Accessed February 15, 2016.
  • Breitbart W, Dibiase L. Current perspectives on pain in AIDS. Oncology. 2002;16:964–968, 972.
  • Tsao JC, Dobalian A, Naliboff BD. Panic disorder and pain in a national sample of persons living with HIV. Pain. 2004;109:172–180.
  • Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: multicentre study. BMJ. 1997;314:23–28.
  • Frich LM, Borgbjerg FM. Pain and pain treatment in AIDS patients: A longitudinal study. J Pain Symptom Manage. 2000;19:339–347.
  • Tsao JC, Stein JA, Dobalian A. Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV. Pain. 2007;133:128–137.
  • Dobalian A, Tsao JC, Duncan RP. Pain and the use of outpatient services among persons with HIV: Results from a nationally representative survey. Med Care. 2004;42:129–138.
  • Tsao JC, Plankey MW, Young MA. Pain, psychological symptoms and prescription drug misuse in HIV: A literature review. J Pain Manag. 2012;5:111–118.
  • Breitbart W, McDonald MV, Rosenfeld B, et al. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain. 1996;68:315–321.
  • Kimball LR, McCormick WC. The pharmacologic management of pain and discomfort in persons with AIDS near the end of life: Use of opioid analgesia in the hospice setting. J Pain Symptom Manage. 1996;11:88–94.
  • Edelman EJ, Gordon K, Becker WC, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013;28:82–90.
  • Simmonds MJ, Novy D, Sandoval R. The differential influence of pain and fatigue on physical performance and health status in ambulatory patients with human immunodeficiency virus. Clin J Pain. 2005;21:200–206.
  • Singer EJ, Zorilla C, Fahy-Chandon B, Chi S, Syndulko K, Tourtellotte WW. Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain. 1993;54:15–19.
  • Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: Implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61:164–170.
  • Merlin JS, Tamhane A, Starrels JL, Kertez S, Saag M, Cropsey K. Factors associated with prescription of opioids and co-prescription of sedating medications in individuals with HIV. AIDS Behav. 2015. doi:10.1007/s10461-015-1178-8
  • Koeppe J, Armon C, Lyda K, Nielsen C, Johnson S. Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain. 2010;26:190–198.
  • Tsao JC, Dobalian A, Moreau C, Dobalian K. Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. J Nerv Ment Dis. 2004;192:111–118.
  • Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry. 2003;160:547–554.
  • Jeevanjee S, Penko J, Guzman D, Miaskowski C, Bangsberg DR, Kushel MB. Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS Behav. 2014;18(7):1352–1358.
  • Gaither JR, Goulet JL, Becker WC, et al. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. J Pain. 2014;15(11):1130–1140.
  • Hansen L, Penko J, Guzman D, Bangsberg DR, Miaskowski C, Kushel MB. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manage. 2011;42:893–902.
  • Robinson-Papp J, Elliott K, Simpson DM, Morgello S. Problematic prescription opioid use in an HIV-infected cohort: The importance of universal toxicology testing. J Acquir Immune Defic Syndr. 2012;61:187–193.
  • Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22:173–181.
  • Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD. HIV infection and risk of overdose: A systematic review and meta-analysis. AIDS. 2012;26:403–417.
  • Onen NF, Barrette EP, Shacham E, Taniguchi T, Donovan M, Overton ET. A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic. Pain Pract. 12:440–448.
  • Lum PJ, Little S, Botsko M, et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 56(Suppl 1):S91–S97.
  • Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care—A qualitative study. J Pain. 2014;15:1148–1155.
  • Starrels JL, Wu B, Peyser D, et al. It made my life a little easier: Primary care providers' beliefs and attitudes about using opioid treatment agreements. J Opioid Manag. 2014;10:95–102.
  • Glaser BG, Straus AL. The discovery of grounded theory: Strategies for qualitative research. New York: Aldine de Gruyter; 1999.
  • Koeppe J, Lyda K, Armon C. Association between opioid use and health care utilization as measured by emergency room visits and hospitalizations among persons living with HIV. Clin J Pain. 2013;29:957–961.
  • Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–728.
  • Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008;22:233–243.
  • Nurutdinova D, Chrusciel T, Zeringue A, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 26:229–234.
  • Richardson J, Barkan S, Cohen M, et al. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care. 2001;32:93–111.
  • Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129:355–362.
  • Morasco BJ, Dobscha SK. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry. 2008;30:93–99.
  • Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–1782.
  • Merlin JS, Westfall AO, Raper JL, et al. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61:164–170.
  • Robinson-Papp J, George MC. Trust and the ethics of chronic pain management in HIV. J Assoc Nurs AIDS Care. 2015;26:509–513.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.